Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).
  • Written by Admin
  • Written date 2019-02-07 09:28:25
  • Inquire 992
 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).
List





Prev PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
Next PharmAbcine, a clinical stage immune-oncology company, today announced that Dr....